106 related articles for article (PubMed ID: 22792463)
21. Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).
Kuhlmann JB; Wensing G; Kuhlmann J
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):143-50. PubMed ID: 24361088
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
[TBL] [Abstract][Full Text] [Related]
23. Gastric Juice-Based Real-Time PCR for Tailored
Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
[TBL] [Abstract][Full Text] [Related]
24. Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.
Jin T; Zhang X; Geng T; Shi X; Wang L; Yuan D; Kang L
Mol Med Rep; 2016 Mar; 13(3):2117-23. PubMed ID: 26781306
[TBL] [Abstract][Full Text] [Related]
25. CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection.
Sagar M; Seensalu R; Tybring G; Dahl ML; Bertilsson L
Scand J Gastroenterol; 1998 Oct; 33(10):1034-8. PubMed ID: 9829356
[TBL] [Abstract][Full Text] [Related]
26. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.
Sim SC; Risinger C; Dahl ML; Aklillu E; Christensen M; Bertilsson L; Ingelman-Sundberg M
Clin Pharmacol Ther; 2006 Jan; 79(1):103-13. PubMed ID: 16413245
[TBL] [Abstract][Full Text] [Related]
27. High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness.
Bernal-Martínez L; Alcazar Fuoli L; Miguel-Revilla B; Carvalho A; Cuétara Garcia MS; Garcia-Rodriguez J; Cunha C; Gómez-García de la Pedrosa E; Gomez-Lopez A
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910893
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults.
Sridharan K; Kataria R; Tolani D; Bendkhale S; Gogtay NJ; Thatte UM
Indian J Pharmacol; 2016; 48(4):350-354. PubMed ID: 27756942
[TBL] [Abstract][Full Text] [Related]
29. Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole.
Lee SJ; Kim WY; Kim H; Shon JH; Lee SS; Shin JG
Drug Metab Dispos; 2009 Nov; 37(11):2262-9. PubMed ID: 19661214
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy.
Tantray JA; Reddy KP; Jamil K; Kumar YS
Int J Cardiol; 2017 Feb; 229():113-118. PubMed ID: 27915083
[TBL] [Abstract][Full Text] [Related]
31. Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles.
Botton MR; Lu X; Zhao G; Repnikova E; Seki Y; Gaedigk A; Schadt EE; Edelmann L; Scott SA
Hum Mutat; 2019 Nov; 40(11):e37-e51. PubMed ID: 31260137
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.
Tassaneeyakul W; Tawalee A; Tassaneeyakul W; Kukongviriyapan V; Blaisdell J; Goldstein JA; Gaysornsiri D
Pharmacogenetics; 2002 Apr; 12(3):221-5. PubMed ID: 11927837
[TBL] [Abstract][Full Text] [Related]
33. Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19.
Arefayene M; Skaar TC; Zhao X; Rae JM; Tanus-Santos JE; Brinkmann U; Brehm I; Salat U; Nguyen A; Desta Z; Flockhart DA
Pharmacogenetics; 2003 Apr; 13(4):199-206. PubMed ID: 12668916
[TBL] [Abstract][Full Text] [Related]
34. Rapid detection of CYP2C18 genotypes by real-time fluorescence polymerase chain reaction.
Mizugaki M; Hiratsuka M; Agatsuma Y; Matsubara Y; Fujii K; Kure S; Narisawa K
J Pharm Pharmacol; 2000 Feb; 52(2):199-205. PubMed ID: 10714950
[TBL] [Abstract][Full Text] [Related]
35. The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome.
Yaşar Ü
Cent Eur J Immunol; 2018; 43(2):220-221. PubMed ID: 30135636
[TBL] [Abstract][Full Text] [Related]
36. CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip.
Sameer AE; Amany GM; Abdela AA; Fadel SA
Can J Clin Pharmacol; 2009; 16(1):e156-62. PubMed ID: 19193970
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of CYP2C19 polymorphisms in the Lebanese population.
Djaffar Jureidini I; Chamseddine N; Keleshian S; Naoufal R; Zahed L; Hakime N
Mol Biol Rep; 2011 Nov; 38(8):5449-52. PubMed ID: 21380557
[TBL] [Abstract][Full Text] [Related]
38. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
[TBL] [Abstract][Full Text] [Related]
39. High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.
Kaneko A; Lum JK; Yaviong L; Takahashi N; Ishizaki T; Bertilsson L; Kobayakawa T; Björkman A
Pharmacogenetics; 1999 Oct; 9(5):581-90. PubMed ID: 10591538
[TBL] [Abstract][Full Text] [Related]
40. Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability.
Ghodke Y; Joshi K; Patwardhan B
Evid Based Complement Alternat Med; 2011; 2011():249528. PubMed ID: 20015960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
